Constantia Pantelidou
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Genetics
- Cancer Research
- Co-authors
- Geoffrey I. ShapiroGerburg M. WulfAditi KothariJennifer L. GuerrieroOlmo SonzogniJos JonkersEmily CheneyPeter Bouwman
- Topics
- PARP inhibition in cancer therapy (4 papers)CAR-T cell therapy research (3 papers)Virus-based gene therapy research (2 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Constantia Pantelidou
8 papers receiving 811 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 528
- Molecular Biology 469
- Immunology 275
- Genetics 95
- Cancer Research 73
Countries citing papers authored by Constantia Pantelidou
This map shows the geographic impact of Constantia Pantelidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantia Pantelidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantia Pantelidou more than expected).
Fields of papers citing papers by Constantia Pantelidou
This network shows the impact of papers produced by Constantia Pantelidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantia Pantelidou. The network helps show where Constantia Pantelidou may publish in the future.
Co-authorship network of co-authors of Constantia Pantelidou
This figure shows the co-authorship network connecting the top 25 collaborators of Constantia Pantelidou. A scholar is included among the top collaborators of Constantia Pantelidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constantia Pantelidou. Constantia Pantelidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 18 | |
| 3 | A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumorsbreakdown → | 226 |
| 4 | 1 | |
| 5 | PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancerbreakdown → | 476 |
| 6 | 46 | |
| 7 | 21 | |
| 8 | 3 | |
| 9 | 21 |
About Constantia Pantelidou
Constantia Pantelidou is a scholar working on Biotechnology, Oncology and Genetics, having authored 9 papers that have together received 812 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), CAR-T cell therapy research (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (528 citations), Immunology (275 citations) and Molecular Biology (469 citations). Constantia Pantelidou has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Geoffrey I. Shapiro, Gerburg M. Wulf, Aditi Kothari, Jennifer L. Guerriero, Olmo Sonzogni, Jos Jonkers, Emily Cheney, Peter Bouwman, Jocelin Pinto and Jessica A. Castrillon. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.